743 related articles for article (PubMed ID: 26331541)
1. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
2. The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.
Lin KT; Lu RM; Tarn WY
Mol Cell Biol; 2004 Oct; 24(20):9176-85. PubMed ID: 15456888
[TBL] [Abstract][Full Text] [Related]
3. CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1.
Hluchý M; Gajdušková P; Ruiz de Los Mozos I; Rájecký M; Kluge M; Berger BT; Slabá Z; Potěšil D; Weiß E; Ule J; Zdráhal Z; Knapp S; Paruch K; Friedel CC; Blazek D
Nature; 2022 Sep; 609(7928):829-834. PubMed ID: 36104565
[TBL] [Abstract][Full Text] [Related]
4. SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns.
Fukumura K; Yoshimoto R; Sperotto L; Kang HS; Hirose T; Inoue K; Sattler M; Mayeda A
Nat Commun; 2021 Aug; 12(1):4910. PubMed ID: 34389706
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP
Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480
[TBL] [Abstract][Full Text] [Related]
6. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
[TBL] [Abstract][Full Text] [Related]
7. Splicing and Dicing MYC-Mediated Synthetic Lethality.
Stine ZE; Dang CV
Cancer Cell; 2015 Oct; 28(4):405-406. PubMed ID: 26461086
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer.
Cieśla M; Ngoc PCT; Cordero E; Martinez ÁS; Morsing M; Muthukumar S; Beneventi G; Madej M; Munita R; Jönsson T; Lövgren K; Ebbesson A; Nodin B; Hedenfalk I; Jirström K; Vallon-Christersson J; Honeth G; Staaf J; Incarnato D; Pietras K; Bosch A; Bellodi C
Mol Cell; 2021 Apr; 81(7):1453-1468.e12. PubMed ID: 33662273
[TBL] [Abstract][Full Text] [Related]
10. Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors.
Thickman KR; Swenson MC; Kabogo JM; Gryczynski Z; Kielkopf CL
J Mol Biol; 2006 Feb; 356(3):664-83. PubMed ID: 16376933
[TBL] [Abstract][Full Text] [Related]
11. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
[TBL] [Abstract][Full Text] [Related]
12. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
[TBL] [Abstract][Full Text] [Related]
13. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
Bowling EA; Wang JH; Gong F; Wu W; Neill NJ; Kim IS; Tyagi S; Orellana M; Kurley SJ; Dominguez-Vidaña R; Chung HC; Hsu TY; Dubrulle J; Saltzman AB; Li H; Meena JK; Canlas GM; Chamakuri S; Singh S; Simon LM; Olson CM; Dobrolecki LE; Lewis MT; Zhang B; Golding I; Rosen JM; Young DW; Malovannaya A; Stossi F; Miles G; Ellis MJ; Yu L; Buonamici S; Lin CY; Karlin KL; Zhang XH; Westbrook TF
Cell; 2021 Jan; 184(2):384-403.e21. PubMed ID: 33450205
[TBL] [Abstract][Full Text] [Related]
14. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
[TBL] [Abstract][Full Text] [Related]
15. The SF3b155 N-terminal domain is a scaffold important for splicing.
Cass DM; Berglund JA
Biochemistry; 2006 Aug; 45(33):10092-101. PubMed ID: 16906767
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional modularity of the U2 snRNP in pre-mRNA splicing.
van der Feltz C; Hoskins AA
Crit Rev Biochem Mol Biol; 2019 Oct; 54(5):443-465. PubMed ID: 31744343
[TBL] [Abstract][Full Text] [Related]
17. Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.
Roybal GA; Jurica MS
Nucleic Acids Res; 2010 Oct; 38(19):6664-72. PubMed ID: 20529876
[TBL] [Abstract][Full Text] [Related]
18. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
[TBL] [Abstract][Full Text] [Related]
19. Saccharomyces cerevisiae NineTeen complex (NTC)-associated factor Bud31/Ycr063w assembles on precatalytic spliceosomes and improves first and second step pre-mRNA splicing efficiency.
Saha D; Khandelia P; O'Keefe RT; Vijayraghavan U
J Biol Chem; 2012 Feb; 287(8):5390-9. PubMed ID: 22215661
[TBL] [Abstract][Full Text] [Related]
20. The splicing factor Prp17 interacts with the U2, U5 and U6 snRNPs and associates with the spliceosome pre- and post-catalysis.
Sapra AK; Khandelia P; Vijayraghavan U
Biochem J; 2008 Dec; 416(3):365-74. PubMed ID: 18691155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
